(Reuters) - In a filing with the U.S. Securities and Exchange Commission, Conmed said it will record a pre-tax gain of about $6.3 million to $6.8 million, after deducting legal and other expenses.
In 2003, Conmed sued Johnson & Johnson and several of its units alleging violations of federal and state antitrust laws.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment